Boston Trust Walden Corp Has $45.01 Million Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Boston Trust Walden Corp lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 531,813 shares of the company’s stock after selling 12,907 shares during the period. Boston Trust Walden Corp owned 3.53% of U.S. Physical Therapy worth $45,007,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in USPH. Precision Wealth Strategies LLC raised its stake in shares of U.S. Physical Therapy by 5.1% during the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock worth $239,000 after buying an additional 137 shares during the last quarter. Texas Permanent School Fund Corp raised its stake in shares of U.S. Physical Therapy by 1.3% in the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after purchasing an additional 170 shares during the period. First Horizon Advisors Inc. lifted its stake in U.S. Physical Therapy by 18.6% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock valued at $110,000 after acquiring an additional 186 shares in the last quarter. Louisiana State Employees Retirement System lifted its position in shares of U.S. Physical Therapy by 2.7% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $702,000 after purchasing an additional 200 shares in the last quarter. Finally, Martin Capital Advisors LLP boosted its stake in shares of U.S. Physical Therapy by 1.6% during the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock worth $1,112,000 after buying an additional 201 shares during the last quarter.

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Kathleen A. Gilmartin bought 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, September 3rd. The stock was bought at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the purchase, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on USPH. Bank of America reissued a “neutral” rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Finally, Barrington Research reissued an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, October 9th.

U.S. Physical Therapy Stock Down 1.4 %

Shares of USPH opened at $80.77 on Friday. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The firm has a 50 day simple moving average of $83.14 and a two-hundred day simple moving average of $92.49. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. The company has a market cap of $1.22 billion, a P/E ratio of 65.67, a P/E/G ratio of 3.94 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The company had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. During the same quarter last year, the company posted $0.76 earnings per share. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Research analysts forecast that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend was Friday, August 23rd. U.S. Physical Therapy’s payout ratio is currently 143.09%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.